Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of AER-271 in Healthy Subjects
NCT03804476Phase 1Completed
- Sponsor
- Aeromics, Inc.
- Start
- Jun 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in ischemic stroke comparing AER-271 with Placebo (2 arms). Primary endpoints: Number of patients that experience adverse events, Number of patients that experience serious adverse events and 2 more. Started Jun 2018; status: completed.
02
Drugs
AER-271
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03804476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03804476.